In longevity and metabolic studies, 5-Amino-1MQ stands out as a clean, versatile molecule backed by growing interest in NAD-based therapeutics
We've seen this exact mistake across hundreds of research protocols, and it compounds when researchers assume "more is better" without verifying their concentration calculations first
It reverses the effects of L-arginine (the NO precursor) and L-NAME (the NO blocker)
If the agency ultimately issues a final determination against listing, compounders would lose any viable legal pathway though substances can be re-nominated in future PCAC cycles or challenged in federal court
BPC-157 is a larger pentadecapeptide derived from gastric juice, primarily studied for tissue repair, gut barrier protection, and angiogenesis a broader research profile than KPV's more targeted anti-inflammatory focus
Are you aiming for systemic rejuvenation or a highly localized, speculative gut effect